港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

陆道培医疗集团（临时代码）

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：- -

开：- -

低：- -

收：- -

数据加载中...

总览公司新闻公告

6年估值涨20倍，陆道培医疗究竟值不值？

公司研究室

一图解码：陆道培医疗IPO 亏损近十亿血液病赛道很烧钱？

陆道培医疗集团冲港股，淡马锡入股，两年九个月亏10亿元

新股前瞻|陆道培：血液病医疗服务市场供需缺口大 “流血”扩张仍需警惕

金融界网站

新股前瞻|陆道培：血液病医疗服务市场供需缺口大 “流血”扩张仍需警惕

智通财经网

国内最大血液病医院陆道培医疗集团递表，近三年累计亏超10亿元

【新股消息 | 陆道培医疗递表港交所为中国最大的血液病医疗服务提供商】智通财经APP获悉，据港交所2022年1月3日披

新股消息 | 陆道培医疗递表港交所为中国最大的血液病医疗服务提供商

【新股IPO】陆道培医疗集团向港交所递交上市申请为中国最大的血液病医疗服务提供商

凤凰网港股

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/90119/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90119","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90119\",,,,,undefined,":{"symbol":"90119","market":"HK","secType":"STK","nameCN":"陆道培医疗集团（临时代码）","latestPrice":0,"timestamp":1747814400000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0,"latestTime":"05-21 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747877400000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1747791000000,1747800000000],[1747803600000,1747814400000]],"volumeRatio":0,"lotSize":0,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90119\",,,,,undefined,":{"symbol":"90119","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90119\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2308209046","title":"6年估值涨20倍，陆道培医疗究竟值不值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2308209046","media":"公司研究室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308209046?lang=zh_cn&edition=fundamental","pubTime":"2023-02-02 12:31","pubTimestamp":1675312260,"startTime":"0","endTime":"0","summary":"虽然近年来迅速扩大规模，但陆道培医疗至今却并未真正实现盈利。究其原因，毛利率过低是陆道培医疗亏损的主要因素之一。河北燕达陆道培医院2015年投入运营，贡献了陆道培医疗70%的业绩。2022年前三季度，燕达陆道培医院创造了8.27亿元的收入，毛利率由截至2021年9月30日止九个月的21.5％增加至2022年同期的23.4％。截至2022年9月30日，公司已租赁医院场地并产生资本支出4280万元。短期内无法盈利的现实，更增加了陆道培医疗","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzIwNjM4MjI4Mg==&mid=2247488542&idx=1&sn=89ffb6d20f6b0d9f20a6a985d5a7ed16&chksm=972321bba054a8ad0ed8793ec3b7409bb7ed23179b7de583103a5c42c36536cd54304b017755#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["90119"],"gpt_icon":0},{"id":"2301190362","title":"一图解码：陆道培医疗IPO  亏损近十亿 血液病赛道很烧钱？","url":"https://stock-news.laohu8.com/highlight/detail?id=2301190362","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301190362?lang=zh_cn&edition=fundamental","pubTime":"2023-01-06 10:48","pubTimestamp":1672973281,"startTime":"0","endTime":"0","summary":"1月3日，陆道培医疗向港交所递交了招股书，计划在主板挂牌上市；由中信证券、招银国际和麦格理担任联席保荐人。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202301_1/3e99e188-e13f-431c-9c99-9be9e73723e6.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202301_1/3e99e188-e13f-431c-9c99-9be9e73723e6.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/63b78be153243c0e604c4041","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["90119"],"gpt_icon":0},{"id":"2301803258","title":"陆道培医疗集团冲港股，淡马锡入股，两年九个月亏10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2301803258","media":"浙江新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301803258?lang=zh_cn&edition=fundamental","pubTime":"2023-01-05 18:58","pubTimestamp":1672916334,"startTime":"0","endTime":"0","summary":"近日，陆道培医疗集团（以下简称“陆道培医疗”）向港交所递交招股书，申请在港股上市，联席保荐人为中信证券、招银国际及麦格理。据悉，陆道培医疗由开创中国血液病治疗先河并奠定血液病医 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20230105/c644077440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["90119","159891"],"gpt_icon":0},{"id":"2301059544","title":"新股前瞻|陆道培：血液病医疗服务市场供需缺口大 “流血”扩张仍需警惕","url":"https://stock-news.laohu8.com/highlight/detail?id=2301059544","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301059544?lang=zh_cn&edition=fundamental","pubTime":"2023-01-04 19:33","pubTimestamp":1672831982,"startTime":"0","endTime":"0","summary":"巨大的未满足的医疗需求加上不断增长的患者基础预计将推动中国血液病医疗服务市场增长。预计医院扩张将成为陆道培未来在血液病医疗服务市场实现增长的基石。　　陆道培医疗的盈利能力有所下滑，毛利率整体呈现下降态势。　　陆道培“流血”扩张的原因，与血液病市场庞大的供需缺口有关。截至2021年，中国约有2170万患者确诊血液系统疾病，其中约有21万例为血液肿瘤新发病例。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2023/01/04193337259347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["90119"],"gpt_icon":0},{"id":"2300282084","title":"新股前瞻|陆道培：血液病医疗服务市场供需缺口大 “流血”扩张仍需警惕","url":"https://stock-news.laohu8.com/highlight/detail?id=2300282084","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300282084?lang=zh_cn&edition=fundamental","pubTime":"2023-01-04 19:33","pubTimestamp":1672831982,"startTime":"0","endTime":"0","summary":"亏损持续扩大的同时，陆道培选择了继续扩张。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20230104/20230104193441_81776.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230104/20230104193441_81776.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/857225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["90119"],"gpt_icon":0},{"id":"1154063162","title":"国内最大血液病医院陆道培医疗集团递表，近三年累计亏超10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154063162","media":"财联社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154063162?lang=zh_cn&edition=fundamental","pubTime":"2023-01-04 18:28","pubTimestamp":1672828131,"startTime":"0","endTime":"0","summary":"陆道培医疗集团向港交所主板提交上市申请。","market":"hk","thumbnail":"https://static.tigerbbs.com/6098c6e789f5cc0074835cd59796a21d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6098c6e789f5cc0074835cd59796a21d"],"rights":{"source":"cailianpress","url":"https://www.cls.cn/detail/1230171","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cls.cn/detail/1230171","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cailianpress","symbols":["159718","90119"],"gpt_icon":0},{"id":"2300849272","title":"【新股消息 | 陆道培医疗递表港交所 为中国最大的血液病医疗服务提供商】智通财经APP获悉，据港交所2022年1月3日披","url":"https://stock-news.laohu8.com/highlight/detail?id=2300849272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300849272?lang=zh_cn&edition=fundamental","pubTime":"2023-01-04 09:30","pubTimestamp":1672795858,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["90119","BK0012","600030","BK0028","BK1516","159891","BK0183","BK0276","LU1997245094.SGD","BK1147","BK1564","BK0196","06030","LU1794554557.SGD","LU1997245177.USD","BK1521","LU1720050803.USD","BK0188"],"gpt_icon":0},{"id":"2300492203","title":"新股消息 | 陆道培医疗递表港交所 为中国最大的血液病医疗服务提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2300492203","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300492203?lang=zh_cn&edition=fundamental","pubTime":"2023-01-04 09:30","pubTimestamp":1672795858,"startTime":"0","endTime":"0","summary":"陆道培招股书显示，根据弗若斯特沙利文的资料，就2021年的收入以及截至2021年12月31日血液病患者的登记床位数量及造血干细胞移植仓位数而言，公司是中国最大的血液病医疗服务提供商。于往绩记录期间，河北燕达陆道培医院于2017年1月被认定为医疗保险定点医疗机构并为公司总收入贡献绝大一部分。北京陆道培医院亦庄院区及北京陆道培医院顺义院区分别于2021年1月和2020年12月被认定为医疗保险定点医疗机构，并因此经历了快速的业务增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/856744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["90119","159891"],"gpt_icon":0},{"id":"2300618450","title":"【新股IPO】陆道培医疗集团向港交所递交上市申请 为中国最大的血液病医疗服务提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2300618450","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300618450?lang=zh_cn&edition=fundamental","pubTime":"2023-01-03 23:20","pubTimestamp":1672759220,"startTime":"0","endTime":"0","summary":"据港交所1月3日文件：陆道培医疗集团向港交所递交上市申请，中信证券、招银国际和麦格理为联席保荐人。根据弗若斯特沙利文的资料，按2021年的造血干细胞移植病例数计算，公司于中国排名第二，且在中国的造血干细胞移植服务市场中，公司在2021年进行的异基因造血干细胞移植数量排名第一，进行的半相合造血干细胞移植数量排名第二。就2021年血液病特检服务产生的收入而言，公司还是该项服务的中国第三大提供商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=fbc886d3f7d0f3086ad4c0f84008727c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","90119","IPO"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90119\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90119\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90119\",market:\"HK\",delay:false,,,undefined,":{}}}